{"nctId":"NCT02386319","briefTitle":"Anxiolytic and Analgesic Effects of Melatonin","startDateStruct":{"date":"2016-08"},"conditions":["Anxiety"],"count":36,"armGroups":[{"label":"Melatonin","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Melatonin"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Melatonin","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria part one:\n\n* Patients who are candidates for breast surgery.\n* BMI between 18 and 30\n* Visible veins in the elbow region\n* Fertile women use anti-contraception and have performed a negative pregnancy test\n\nExclusion Criteria part one:\n\n* Patients, who use daily opioids, benzodiazepines or melatonin\n* Patients diagnosed with a psychiatric disorder (defined as in medical treatment)\n* Patients with severe physical disease (ASA 3-4)\n* Patients with previous or ongoing alcohol or drug abuse\n* Patients with liver disease (defined as in medical treatment)\n* Patients diagnosed sleep disturbances\n* Patients who are unable to cooperate according to the protocol\n* Patients with allergy to melatonin\n\nInclusion Criteria part two:\n\n\\- Male patients who are candidates for inguinal or umbilical hernia reapir\n\nExclusion Criteria part two:\n\n* Patients, who use daily opioids, benzodiazepines or melatonin\n* Patients diagnosed with a psychiatric disorder (defined as in medical treatment)\n* Patients with severe physical disease (ASA 3-4)\n* Patients with previous or ongoing alcohol or drug abuse\n* Patients with liver disease (defined as in medical treatment)\n* Patients diagnosed sleep disturbances\n* Patients who are unable to cooperate according to the protocol\n* Patients with allergy to melatonin\n\nWithdrawal- and drop-out criteria part 2:\n\n* Patients can withdraw at any time during trial\n* Complications during surgery occur that lead to:\n\n  1. Immediate reoperation\n  2. Hospitalization to intensive care unit\n* If it is considered in the best interest of the patients physical- and psychological health to withdraw from the trial","healthyVolunteers":false,"sex":"FEMALE","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Preoperative Anxiety","description":"The \"State\" scale of the State-Trait Anxiety Inventory (STAI). Construct: Current level of anxiety. Scale range: 20-40 (higher scores indicate higher level of current anxiety) Scores are calculated according to the STAI scoring manual by adding point from each item (possible point for each item is 1-4).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]}]},{"type":"SECONDARY","title":"Postoperative Anxiety","description":"State-Trait Anxiety Index","classes":[]},{"type":"SECONDARY","title":"Pre- and Postoperative Anxiety","description":"Visual analog scale","classes":[]},{"type":"SECONDARY","title":"Intraoperative Requirement of Remifentanil","description":"Âµg/kg/min","classes":[]},{"type":"SECONDARY","title":"Intraoperative Requirement of Propofol","description":"mg/kg/min","classes":[]},{"type":"SECONDARY","title":"Use of Rescue-opioids in the PACU","description":"dose","classes":[]},{"type":"SECONDARY","title":"Use of Rescue-opioids in the Ward","description":"dose","classes":[]},{"type":"SECONDARY","title":"Perioperative Sleep Quality","description":"Visual analog scale","classes":[]},{"type":"SECONDARY","title":"General Well-being and Fatigue","description":"Visual analog scale","classes":[]},{"type":"SECONDARY","title":"Plasma Concentrations of Melatonin","description":"pg/ml","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":16},"commonTop":[]}}}